SCHEMBL9665192

SCHEMBL9665192

CC1(C)SCCC(C(=O)O)NC1=O

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.70
KMT2A Q03164 3/20 0.51
ITGA4 P13612 2/20 0.32
MAPT P10636 3/20 0.32
MAPK1 P28482 1/20 0.32
MEN1 O00255 2/20 0.31
GAA P10253 1/20 0.31
KDM4E B2RXH2 1/20 0.30
CYP2D6 P10635 2/20 0.30
LMNA P02545 2/20 0.30
BLM P54132 2/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2C19 P33261 1/20 0.30
RAB9A P51151 1/20 0.30
THRB P10828 1/20 0.30
PMP22 Q01453 1/20 0.30
CAD P27708 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9662670 0.83 HTT (0.57) HTTKMT2AITGA4
SCHEMBL2333909 0.82 HTT (1.00) HTTKMT2AMAPTMAPK1MEN1
SCHEMBL9664010 0.82 KMT2A (0.72) HTTKMT2ATSHRCYP1A2
SCHEMBL9487701 0.72 HTT (0.70) HTTKMT2AITGA4MAPTMEN1
SCHEMBL10949228 0.72 HTT (0.70) HTTKMT2AITGA4MAPTMEN1
SCHEMBL13439524 0.72 HTT (0.42) HTTKMT2AMAPTMEN1GAA
SCHEMBL29544906 0.69 HTT (0.59) HTTKMT2AITGA4
SCHEMBL1973599 0.68 HTT (0.55) HTTKMT2AITGA4MAPTMEN1
SCHEMBL5550440 0.68 HTT (0.55) HTTKMT2AITGA4MAPTMEN1
SCHEMBL9662640 0.67 KMT2A (0.60) HTTKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5128467-A Immunomodulation, liver disorders SANTEN PHARMACEUTICAL CO., LTD. (JP) 1992-07-07 US disclosed
US-5082836-A Autoimmune diseases SANTEN PHARMACEUTICAL CO., LTD. (JP) 1992-01-21 US disclosed
US-5041435-A Treatment of Liver Disorders and Autoimmune Diseases SANTEN PHARMACEUTICAL CO., LTD. (JP) 1991-08-20 US disclosed
EP-0356006-A1 Cyclic sulfur-containing compounds SANTEN PHARMACEUTICAL CO., LTD. (JP) 1990-02-28 EP disclosed